COVID-19: Registry Study Offers Reassurance That ECMO Can Help Sickest Patients
Data from the Extracorporeal Life Support Organization registry shows experienced centers should consider using extracorporeal membrane oxygenation to treat COVID-19-related respiratory failure.
You may also be interested in...
The Israeli company raised $16m to support its Augmented Respiration Technology, a novel approach for delivering oxygen directly into the venous system. The company expects to earn FDA clearance for first product by 2023.
The Swedish company has seen a spike in orders of acute care products to treat COVID-19 patients and plans a multi-million investment to expand long-term ECMO production.
According to reports from Caixin and Bloomberg, TikTok’s Chinese owner ByteDance paid about $1.5bn for Amcare Healthcare, the operator of women’s and children’s hospitals in major Chinese cities.